We are live on ! Find out more
KZIA

Kazia Therapeutics
KZIA

10 hedge funds and large institutions have $569K invested in Kazia Therapeutics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

38% less capital invested

Capital invested by funds: $922K → $569K (-$353K)

41% less funds holding

Funds holding: 17 → 10 (-7)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
10
Holders Change
-7
Holders Change %
-41.18%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
–
Closed
9
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$555K
2
JP Morgan Chase
JP Morgan Chase
New York
+$15.8K
3
MCM
MAI Capital Management
Ohio
+$13K
4
UBS Group
UBS Group
Switzerland
+$12K
5
Morgan Stanley
Morgan Stanley
New York
+$6.54K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$26K
2
Jane Street
Jane Street
New York
-$19.8K
3
UBV
United Bank (Virginia)
Virginia
-$18.9K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$13K
5
XT
XTX Topco
Cayman Islands
-$10.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
1
MAI Capital Management
Ohio
$246K +$13K +564 +2%
Barclays
2
Barclays
United Kingdom
$212K +$555K +24,000 New
UBS Group
3
UBS Group
Switzerland
$48.8K +$12K +520 +10%
Morgan Stanley
4
Morgan Stanley
New York
$41.5K +$6.54K +283 +6%
JP Morgan Chase
5
JP Morgan Chase
New York
$12.8K +$15.8K +684 +90%
RhumbLine Advisers
6
RhumbLine Advisers
Massachusetts
$4.91K – – –
Citigroup
7
Citigroup
New York
$1.27K +$3.33K +144 New
Simplex Trading
8
Simplex Trading
Illinois
$1K +$3.05K +132 +1,320%
Osaic Holdings
9
Osaic Holdings
Arizona
$88 – – –
AF
10
Allworth Financial
California
$11 – – –
Wells Fargo
11
Wells Fargo
California
$4 -$231 -10 Closed
Citadel Advisors
12
Citadel Advisors
Florida
– -$26K -1,210 Closed
Jane Street
13
Jane Street
New York
– -$19.8K -922 Closed
UBV
14
United Bank (Virginia)
Virginia
– -$18.9K -880 Closed
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
– -$13K -610 Closed
XT
16
XTX Topco
Cayman Islands
– -$10.1K -468 Closed
CAPTRUST Financial Advisors
17
CAPTRUST Financial Advisors
North Carolina
– -$6.56K -305 Closed
Geode Capital Management
18
Geode Capital Management
Massachusetts
– -$6.36K -296 Closed
TCM
19
Traynor Capital Management
Pennsylvania
– -$4.3K -200 Closed
AF
20
Advisornet Financial
Minnesota
– -$2 – –

KZIA Hedge Fund Activity: Q4 2024 in Review

10 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2024, worth a combined $569K — down 38% from $922K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of KZIA and 2 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 5 added.

The largest buyer was Barclays, opening a new position worth an estimated $555K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26K sold.

  • 10 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2024, down from 17 in Q3 2024.
  • Funds reported $569K of Kazia Therapeutics stock for Q4 2024, down 38% quarter-over-quarter.
  • 2 funds opened new Kazia Therapeutics positions in Q4 2024 and 9 closed out, a net change of -7 holders.
  • The largest Kazia Therapeutics buyer in Q4 2024 was Barclays, an estimated $555K added.
  • The largest Kazia Therapeutics seller in Q4 2024 was Citadel Advisors, an estimated $26K sold.

Based on aggregated 13F filings for Q4 2024.